The patients signed up to take Galleri, a prescription oncology detection test, and later received letters suggesting they had cancer.
Category: Forbes
LabDAO Is Charting The Future Of Open-Source AI For Drug Discovery
Read about LabDAO’s latest advance in moving towards such a future with their PLEX command-line tool for open-source drug discovery.
Coherus BioSciences And Mark Cuban’s Drug Company Aim To Disrupt Humira-Referenced Biosimilar Space With Launch Of Yusimry At A 85% Discount
Coherus BioSciences and Mark Cuban’s Cost Plus Drug Company will shake up the Humira and Humira-referenced biosimilar space with the launch of Yusimry at a 85% discount.
Coherus BioSciences And Mark Cuban’s Drug Company Aim To Disrupt Humira-Referenced Biosimilar Space With Launch Of Yusimry At A 85% Discount
Coherus BioSciences and Mark Cuban’s Cost Plus Drug Company will shake up the Humira and Humira-referenced biosimilar space with the launch of Yusimry at a 85% discount.
How Dental Visits Can Be Made Less Stressful For Autistic Children
Autistic children tend to struggle with poor oral health a lot more than their neurotypical peers.
Restoring The Sense Of Touch: Advances In Artificial Skin Technology
Advances in haptic skin may restore the sense of touch to those who have lost limbs or touch sensation.
U.S. Population Flatlining As Birth Rate Stagnates In 2022
Teen birth rates reached record lows in 2022 while birth rates for older women increased.
Pandemic Burnout Turns More Health Professionals Into ‘Traveling’ Workers
Three in four allied health professionals are becoming traveling workers at the beginning of their careers thanks to burnout, a new analysis shows.
Pharmaceutical Industry Ought To Justify Drug Prices On Value, Not R&D Costs
Sometimes a lot of R&D goes into only marginally effective drugs. Other times, drugs with relatively minimal amounts of R&D turn out to have a lot of value.
Why You Should Pay Attention To Diabetes
This means that more than 1 in 3 Americans has prediabetes, which is more than the number of Americans that have cancer, heart disease, or stroke.
